Table 1 Summary of patient characteristics. FIGO, International Federation of Gynecology and Obstetrics
From: Predictive value of RAD51 on the survival and drug responsiveness of ovarian cancer
Characteristics | Total patients | RAD51 low | RAD51 high | P values | ||
|---|---|---|---|---|---|---|
(N = 126) | (N = 81) | (N = 45) | ||||
No | No | % | No | % | ||
Histology | High-grade serous | High-grade serous | High-grade serous | |||
Age at diagnosis (years) | ||||||
≤ 50 | 53 | 36 | 44.44% | 17 | 37.78% | 0.5726a |
> 50 | 73 | 45 | 55.56% | 28 | 62.22% | |
FIGO stage | ||||||
I | 9 | 6 | 7.41% | 3 | 6.67% | 0.5332b |
II | 22 | 15 | 18.52% | 7 | 15.56% | |
III | 84 | 54 | 66.66% | 30 | 66.66% | |
IV | 11 | 6 | 7.41% | 5 | 11.11% | |
Ascites | ||||||
Yes | 81 | 53 | 65.43% | 28 | 62.22% | 0.4916b |
No | 25 | 17 | 20.99% | 8 | 17.78% | |
Unknown | 20 | 11 | 13.58% | 9 | 20.00% | |